1. Shen, Mengjia, Cao, Shiyu, Long, Xinyi, Ye, Feng, Bu, Hong. 2024. DNAJC12 causes breast cancer chemotherapy resistance by repressing doxorubicin-induced ferroptosis and apoptosis via activation of AKT. In Redox biology, 70, 103035. doi:10.1016/j.redox.2024.103035. https://pubmed.ncbi.nlm.nih.gov/38306757/
2. Wang, Lulu, Ma, Dingyuan, Sun, Yun, Zhang, Jingjing, Xu, Zhengfeng. 2023. Identification of two novel DNAJC12 gene variants in a patient with mild hyperphenylalaninemia. In Gene, 869, 147397. doi:10.1016/j.gene.2023.147397. https://pubmed.ncbi.nlm.nih.gov/36990253/
3. Wang, Jin, Huang, Haihua, Liu, Fabing. . DNAJC12 activated by HNF1A enhances aerobic glycolysis and drug resistance in non-small cell lung cancer. In Annals of translational medicine, 10, 492. doi:10.21037/atm-22-1475. https://pubmed.ncbi.nlm.nih.gov/35571408/
4. Lin, Mianjie, Wang, Ya-Nan, Ye, Yixin, Guo, Fengbiao, Chen, Haibin. 2021. DNAJC12 as a Mediator Between ESR1 and ERBB4 in Breast Carcinoma Cells. In Frontiers in oncology, 11, 582277. doi:10.3389/fonc.2021.582277. https://pubmed.ncbi.nlm.nih.gov/33718139/
5. Fan, Yu, Yang, Zhi-Hua, Li, Fang, Shi, Chang-He, Xu, Yu-Ming. 2018. DNAJC12 mutation is rare in Chinese Han population with Parkinson's disease. In Neurobiology of aging, 68, 159.e1-159.e2. doi:10.1016/j.neurobiolaging.2018.04.012. https://pubmed.ncbi.nlm.nih.gov/29801756/
6. Gallego, Diana, Leal, Fátima, Gámez, Alejandra, Martínez, Aurora, Pérez, Belén. 2020. Pathogenic variants of DNAJC12 and evaluation of the encoded cochaperone as a genetic modifier of hyperphenylalaninemia. In Human mutation, 41, 1329-1338. doi:10.1002/humu.24026. https://pubmed.ncbi.nlm.nih.gov/32333439/
智鼠故事 
